– because cancer patients are individuals

News and Press Releases

2019-12-13

News

Hospitals and cancer care givers can now offer the IndiTreat test to their cancer patients.

Already in 2020, cancer patients in selected hospitals can receive IndiTreat-guided medical treatment. The IndiTreat® analysis tool, a 2cureX proprietary...

2019-12-13

Press releases regulatory

2cureX presented progression in the IndiTreat® immuno-oncology assay development at the ESMO Immuno-Oncology Congress in Geneva 11-14 Dec. 2019.

2cureX AB (“2cureX”, NASDAQ: 2CUREX) announces that the company presented significant progression of the IndiTreat® test for individualizing immuno-oncological treatment...

2019-12-10

News

2cureX launches IndiTreat.com as an important component of 2cureX’s preparation for the product launch of IndiTreat® in 2020

2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has launched www.IndiTreat.com. This website provides detailed information to colorectal...

To the news archive

Meet 2cureX

March 17, 2020

Oncology Convention 2020, Birmingham, UK

Click here for more information

February 19-22, 2020

German Cancer Congress, 34 Deutscher Krebs Kongress 2020, Berlin, Germany

Click here for more information

December 11-14, 2019

ESMO Immuno-Oncology Congress 2019

Click here for more information

Contact information

2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint